harrietteracine23
  • 64
  • 0
Non-Alcoholic Steatohepatitis (NASH) treatment market eyes $94B milestone by next decade
The Non-Alcoholic Steatohepatitis (NASH) treatment market is set to grow rapidly. It is expected to rise from US$ 7.9 billion in 2024 to about US$ 94.0 billion by 2034, growing at a CAGR of 28.1% during the forecast period.
View Text Version Category : 24
  • Follow
  • 0
  • Embed
  • Share
  • Upload
Related publications